自性向的合性利用巨型皮诺细胞体进入细胞,以在小细胞肺癌中增强抗增殖性自
Jingyi Chen1, Shan Gao1, Xiaozhe Zhang1
1Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong 999077, China.
Pharmaceutics
|December 31, 2025
概括
新型Tat-SP4针对小细胞肺癌 (SCLC) 的自,通过诱导细胞死亡和线粒体功能障碍来抑制癌细胞增殖和瘤生长.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子治疗学分子治疗学
背景情况:
- 小细胞肺癌 (SCLC) 是一种具有侵略性的癌症,由于遗传复杂性,治疗选择有限.
- 向疗法在SCLC中表现出有限的成功.
- 自在SCLC中起着至关重要的作用,但需要有效的向策略.
研究的目的:
- 评估Tat-SP4的抗增殖作用,这是一个针对自细胞的合,在SCLC中.
- 研究Tat-SP4作用的机制,包括其对自和线粒体功能的影响.
- 在临床前SCLC模型中评估Tat-SP4的治疗潜力.
主要方法:
- 在SCLC细胞中评估了自标记物 (p62,LC3) 和线粒体功能 (Δψm,OCR).
- 使用体外活力测定和体外异种移植模型确定了抗增殖效应.
- 通过Ca2+成像和药理抑制研究了细胞吸收.
主要成果:
- Tat-SP4诱导的自和自 (自依赖细胞死亡),损害了SCLC的增殖.
- 塔特-SP4导致线粒体功能障碍和氧化酸化受损 (OXPHOS).
- 塔特-SP4通过巨细胞酶进入细胞,触发可测量的细胞外Ca2+流入.
结论:
- Tat-SP4在体外对SCLC细胞表现出显著的抗增殖作用,并在体内抑制瘤生长.
- 巨型皮诺细胞体介导着Tat-SP4细胞进入,可以通过Ca2+流入来监测.
- Tat-SP4通过利用巨细胞结核和将自转化为细胞死亡途径,为SCLC提供了一种新的治疗策略.
相关概念视频
Autophagy
5.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.6K
Delivery Pathways to the Lysosome
8.7K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.7K
Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K
Phagocytosis of Apoptotic Cells
4.9K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
4.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


